In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs

被引：15
|
作者：
Lautzenhiser, SJ [1 ]
Fialkowski, JP [1 ]
Bjorling, D [1 ]
Rosin, E [1 ]
机构：
[1] Univ Wisconsin, Sch Vet Med, Madison, WI USA
来源：
RESEARCH IN VETERINARY SCIENCE | 2001年 / 70卷 / 03期
关键词：
D O I：
10.1053/rvsc.2001.0466
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
The objective of the study was to determine the in vitro interaction between enrofloxacin and ciprofloxacin against Escherichia coli and staphylococcal isolates from dogs. The microdilution checkerboard assay was used to determine the interaction of the drugs against 50 E coli and 50 P-haemolytic staphylococcal clinical isolates. The checkerboard assay revealed that the activity of enrofloxacin and ciprofloxacin was additive against E coli and staphylococcal clinical isolates. It was concluded that for bacterial species against which ciprofloxacin is more potent than enrofloxacin, the in vivo transformation of enrofloxacin to ciprofloxacin may enhance the efficacy of enrofloxacin, if additivity of the drugs is confirmed in vivo. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码：239 / 241
页数：3
相关论文
共 50 条
  • [31] Synergistic Antibacterial and Antibiofilm Activity of the MreB Inhibitor A22 Hydrochloride in Combination with Conventional Antibiotics against Pseudomonas aeruginosa and Escherichia coli Clinical Isolates
    Kotzialampou, Anastasia
    Protonotariou, Efthymia
    Skoura, Lemonia
    Sivropoulou, Afroditi
    [J]. INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2021, 2021
  • [32] In Vitro Antibacterial Activity and Mechanism of Monocaprylin against Escherichia coli and Staphylococcus aureus
    Wang, Jianyu
    Ma, Maomao
    Yang, Jun
    Chen, Long
    Yu, Ping
    Wang, Jun
    Gong, Deming
    Deng, Shuguang
    Wen, Xuefang
    Zeng, Zheling
    [J]. JOURNAL OF FOOD PROTECTION, 2018, 81 (12) : 1988 - 1996
  • [33] In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK
    Hopkins, Katie L.
    Mushtaq, Shazad
    Richardson, Judith F.
    Doumith, Michel
    de Pinna, Elizabeth
    Cheasty, Tom
    Wain, John
    Livermore, David M.
    Woodford, Neil
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (05) : 431 - 437
  • [34] Antibacterial In-vitro-Activity of Essential Oils against Clinical Isolates of Bacteria relevant for Veterinary Medicine from Dogs, Cats, and Horses
    Bismarck, Doris
    Schneider, Marianne
    Mueller, Elisabeth
    [J]. COMPLEMENTARY MEDICINE RESEARCH, 2017, 24 (03) : 153 - 163
  • [35] Ib-M6 Antimicrobial Peptide: Antibacterial Activity against Clinical Isolates of Escherichia coli and Molecular Docking
    Florez-Castillo, J. M.
    Rondon-Villareal, P.
    Ropero-Vega, J. L.
    Mendoza-Espinel, S. Y.
    Moreno-Amezquita, J. A.
    Mendez-Jaimes, K. D.
    Farfan-Garcia, A. E.
    Gomez-Rangel, S. Y.
    Gilberto Gomez-Duarte, Oscar
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (02):
  • [36] Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa
    Pasquali, Frederique
    Manfreda, Gerardo
    [J]. VETERINARY MICROBIOLOGY, 2007, 119 (2-4) : 304 - 310
  • [37] In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli
    Wang, Yale
    Li, He
    Xie, Xiaoqian
    Wu, XiaoHan
    Li, Xinxin
    Zhao, Zeyue
    Luo, Shasha
    Wan, Zhijie
    Liu, Jingjing
    Fu, Lei
    Li, Xiaotian
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 351 - 359
  • [38] Effect of the bovine serum and persister cells on the efficacy of enrofloxacin and ciprofloxacin against a strain of Escherichia coli
    Gray, Z.
    Patricelli, P.
    Dell'elce, A.
    Presa Rossa, C.
    Ramirez, E.
    Formentini, E.
    [J]. REVUE DE MEDECINE VETERINAIRE, 2017, 168 (7-9) : 173 - 182
  • [39] Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin
    Aktas, Z
    Gönüllü, N
    Salcioglu, M
    Bal, Ç
    Ang, Ö
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (03) : 196 - 200
  • [40] In-vitro activity of mecillinam against urine isolates of Escherichia coli from outpatient departments in Germany
    Kresken, Michael
    Koerber-Irrgang, Barbara
    Naber, Kurt G.
    [J]. AKTUELLE UROLOGIE, 2017, 48 (03) : 243 - 247
12345